Page last updated: 2024-08-16

mitomycin and crizotinib

mitomycin has been researched along with crizotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deihimi, S; Dicker, DT; El-Deiry, WS; Lev, A; Lulla, AR; Shagisultanova, E; Xiu, J	1

Other Studies

1 other study(ies) available for mitomycin and crizotinib

Article	Year
Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer. Cancer biology & therapy, 2017, Sep-02, Volume: 18, Issue:9 Topics: Alleles; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Crizotinib; Disease Models, Animal; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Genes, BRCA2; Humans; Immunohistochemistry; Mice; Mitomycin; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Xenograft Model Antitumor Assays	2017

Article

Year

Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer.

Cancer biology & therapy, 2017, Sep-02, Volume: 18, Issue:9

Topics: Alleles; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Crizotinib; Disease Models, Animal; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Genes, BRCA2; Humans; Immunohistochemistry; Mice; Mitomycin; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Xenograft Model Antitumor Assays

2017